2006
DOI: 10.1002/humu.20354
|View full text |Cite
|
Sign up to set email alerts
|

TGFBR1andTGFBR2mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome

Abstract: Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder characterized by manifestations in the cardiovascular, skeletal, ocular, and other organ systems. MFS type1 (MFS1) is caused by mutations in the gene encoding fibrillin (FBN1). Recently, the transforming growth factor-beta receptor-2 gene, TGFBR2, has been shown to be associated with a second type of this disorder with typically mild or absent ocular involvement (MFS type 2; MFS2). Several point mutations were found in the highly conserv… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
131
0
3

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 178 publications
(138 citation statements)
references
References 18 publications
4
131
0
3
Order By: Relevance
“…Following the first report of TGFBR2 mutations in MFS (Mizuguchi et al 2004), LDS, TAAD2, SGS, and FS were recognized as TGFBR mutation-related disorders. Although the original MFS2 patients with TGFBR2 mutations (Mizuguchi et al 2004) could not be reasonably re-examined for the presence of LDS features such as bifid uvula, hypertelorism, craniosynostosis, and arterial tortuosity, at least three reports have since described TGFBR1 or TGFBR2 mutations in classic MFS patients in whom LDS had been ruled out (Disabella et al 2006;Matyas et al 2006;Singh et al 2006). (Singh et al 2006).…”
Section: Germline Tgfbr Mutations and Connective Tissue Disordersmentioning
confidence: 99%
See 3 more Smart Citations
“…Following the first report of TGFBR2 mutations in MFS (Mizuguchi et al 2004), LDS, TAAD2, SGS, and FS were recognized as TGFBR mutation-related disorders. Although the original MFS2 patients with TGFBR2 mutations (Mizuguchi et al 2004) could not be reasonably re-examined for the presence of LDS features such as bifid uvula, hypertelorism, craniosynostosis, and arterial tortuosity, at least three reports have since described TGFBR1 or TGFBR2 mutations in classic MFS patients in whom LDS had been ruled out (Disabella et al 2006;Matyas et al 2006;Singh et al 2006). (Singh et al 2006).…”
Section: Germline Tgfbr Mutations and Connective Tissue Disordersmentioning
confidence: 99%
“…Although the original MFS2 patients with TGFBR2 mutations (Mizuguchi et al 2004) could not be reasonably re-examined for the presence of LDS features such as bifid uvula, hypertelorism, craniosynostosis, and arterial tortuosity, at least three reports have since described TGFBR1 or TGFBR2 mutations in classic MFS patients in whom LDS had been ruled out (Disabella et al 2006;Matyas et al 2006;Singh et al 2006). (Singh et al 2006). However, it should be noted that arterial tortuosity, a cardinal feature of LDS, was not systematically evaluated in any of the four studies (Disabella et al 2006;Matyas et al 2006;Sakai et al 2006;Singh et al 2006).…”
Section: Germline Tgfbr Mutations and Connective Tissue Disordersmentioning
confidence: 99%
See 2 more Smart Citations
“…12 Dysregulated TGF-bsignaling by mutations in the receptor genes, TGFBR1 and TGFBR2, causes thoracic aortic aneurysm (TAA) syndromes, including Marfan syndrome type II (OMIM 154705), 13,14 Loeys-Dietz syndrome (OMIM 609192), 14,15 and thoracic aortic aneurysms leading to type A dissections. 16,17 Although these syndromes are clinically distinct, their phenotypes overlap, with TAA and aortic dissections as the common denominator.…”
Section: Introductionmentioning
confidence: 99%